✦ LIBER ✦

Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines

✍ Scribed by Alex J Eustace; John Crown; Martin Clynes; Norma O'Donovan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical evaluation of dasatinib in m

✍ A.J. Eustace; J. Crown; M. Clynes; N. O'Donovan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Preclinical pharmacokinetics and in vitr

✍ Amrita V. Kamath; Jian Wang; Francis Y. Lee; Punit H. Marathe 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 341 KB

Dasatinib: A potent SRC inhibitor in cli

✍ John Araujo; Christopher Logothetis 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 345 KB

361 Preclinical activity of AZD0530, a n

✍ T.P. Green; M. Fennell; R. Whittaker; J. Curwen; V. Jacobs; J. Allen; P.A. Ple; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 145 KB

254 cKIT overexpression and wild-type NR

✍ F. Journe; M. Wiedig; R. Morandini; F. Sales; G. Ghanem; A. Awada 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Preclinical evaluation of the AKT inhibi

✍ Ma, Brigette B. Y.; Lui, Vivian W. Y.; Hui, Connie W. C.; Lau, Cecilia P. Y.; Wo 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 691 KB